 SAN CARLOS, Calif., Feb. 17, 2021 GLOBE NEWSWIRE -- BioCardia, Inc. Nasdaq: BCDA a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced clinical leadership changes. 